🟠 Moderate Evidence
The UK Health Security Agency has updated its comprehensive guidance on hantaviruses, highlighting the continued importance of surveillance for these rare but potentially fatal viral infections. The guidance emphasises that while hantavirus infections remain uncommon in the UK, healthcare professionals must maintain awareness due to the severity of associated diseases and potential for imported cases from endemic regions.
Key takeaways
- Hantaviruses cause two distinct clinical syndromes with case fatality rates varying from 1% to over 50%
- Human infections occur through inhalation of aerosolised rodent excreta or direct contact with infected animals
- No specific antiviral treatment or vaccine exists for hantavirus infections
Two Distinct Hantavirus Disease Patterns
Clinical syndromes and mortality rates by geographic region
Source: UK Health Security Agency, 2024 | Georgian Medical Journal News
Two Clinical Syndromes with Distinct Geographic Patterns
Hantaviruses cause two primary clinical syndromes that vary significantly by geographic location and viral species. According to the UK Health Security Agency, hantavirus pulmonary syndrome (HPS) predominantly occurs in the Americas and carries case fatality rates ranging from 20% to over 50%.
Haemorrhagic fever with renal syndrome (HFRS) is more common in Europe and Asia, with mortality rates typically between 1% and 15% depending on the viral species involved. The World Health Organization recognises HFRS as a significant public health concern in endemic regions, particularly parts of China, Korea, and Eastern Europe.
Transmission Through Rodent Reservoirs
Human hantavirus infections occur primarily through inhalation of virus-contaminated aerosols from rodent urine, faeces, or saliva. The UK Health Security Agency guidance emphasises that different hantavirus species are associated with specific rodent hosts, creating distinct geographic risk patterns.
Occupational exposure represents a significant risk factor, particularly for individuals working in agriculture, forestry, or pest control. The US Centers for Disease Control and Prevention has documented increased transmission risk during activities that disturb rodent nesting areas or contaminated environments.
Diagnostic Challenges and Laboratory Confirmation
Early diagnosis of hantavirus infections remains challenging due to non-specific initial symptoms that may resemble influenza or other viral infections. The UK guidance stresses the importance of obtaining detailed travel and exposure histories from patients presenting with compatible symptoms.
Laboratory confirmation requires specialised testing including RT-PCR, antigen detection, or serology. According to the guidance, samples should be processed in appropriate biosafety facilities due to the potential severity of infection and the need for specialised expertise in interpretation.
Healthcare professionals must maintain high clinical suspicion for hantavirus infection in patients with compatible symptoms and relevant exposure history, particularly those with recent travel to endemic areas or occupational rodent exposure.
— UK Health Security Agency Guidance (2024)
What this means
Frequently asked questions
How common are hantavirus infections in the UK?
Hantavirus infections are rare in the UK, with most cases being imported from endemic regions. The UK Health Security Agency maintains surveillance but indigenous transmission remains uncommon.
Is there a vaccine available for hantavirus?
Currently, no vaccine is available for hantavirus infections. Prevention focuses on avoiding exposure to rodent excreta and implementing appropriate control measures in high-risk environments.
What is the treatment for hantavirus infection?
No specific antiviral treatment exists for hantavirus infections. Management is primarily supportive care, with intensive monitoring for respiratory and renal complications depending on the syndrome.
The updated UK Health Security Agency guidance reinforces the need for continued vigilance regarding hantavirus infections, particularly as global travel patterns and climate change may influence disease distribution. Healthcare systems must maintain diagnostic capabilities and clinical awareness to ensure rapid identification and appropriate management of these severe but preventable infections.
Source: UK Health Security Agency Hantavirus Guidance
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Editorial standards. This article was produced under the GMJ News editorial process, with oversight by the GMJ Editorial Board. Our editorial process. Spotted an error? Contact the editorial team.
